Budesonide

Alternative Names: Budesonide oral suspension (BOS), Eohilia, Budesonide orodispersible tablet (BOT), Jorveza, Oral viscous budesonide (OVB)

Budesonide is a swallowed corticosteroid used to reduce inflammation in eosinophilic esophagitis (EoE). Unlike inhaled budesonide used for asthma, EoE formulations are swallowed so the medication coats the esophagus directly. Budesonide is available as FDA-approved oral suspension formulations, European orodispersible tablets, and compounded oral viscous preparations. Common side effects can include oral thrush and mild throat irritation.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: Oral

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the provided review, Budesonide is reported as a first-line steroid treatment for eosinophilic esophagitis that many people find effective for improving swallowing, food impaction, and esophageal irritation, with improvements also visible on biopsy. However, effectiveness varies among individuals and symptoms may return after stopping the medication.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
4.0
1 = Very Expensive 5 = Very Affordable

4.0

Affordable
Relief Speed
2.0
1 = No Relief 5 = Immediate Relief

2.0

Slow Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
5.0
1 = Third-line or more 5 = First-line

5.0

First-line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the provided review, Budesonide is reported as a first-line steroid treatment for eosinophilic esophagitis that many people find effective for improving swallowing, food impaction, and esophageal irritation, with improvements also visible on biopsy. However, effectiveness varies among individuals and symptoms may return after stopping the medication.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
Budesonide is a steroid medication commonly used as a first-line treatment for eosinophilic esophagitis (EoE) to help reduce inflammation in the esophagus. It is often swallowed as a liquid, slurry, or dissolvable tablet so the medication coats the esophagus rather than being inhaled into the lungs. Many people report improvement in swallowing, food getting stuck, and irritation after treatment, although results can vary and symptoms may return after stopping therapy. Budesonide has become one of the most commonly used treatments for EoE because it can improve both symptoms and inflammation seen on biopsy.
#ReviewersPreferred #Affordable #CoveredByInsurance #SlowRelief #MildEffect #First-line #Rescue/EmergencyUse